Memo to: Medical and Science Journalists
From: Bill Glitz; Institute for Clinical PET (Positron Emission Tomography)
Subject: October 17 12 Noon Media Briefing on Clinical Uses of Positron Emission Tomography at 12th Annual International PET Conference In Washington
WHAT: Media briefing to present and discuss new peer reviewed research findings on clinical efficacy of positron emission tomography (PET)
WHERE: Washington Boardroom on the Constitution Concourse (Level 3B) of Washington's Grand Hyatt Hotel; 1000 H Street NW
WHEN: Tuesday, October 17 at 12 noon during the 12th Annual International PET Conference
WHY: To learn about new research findings on clinical uses of PET
WHO: Briefing is being coordinated by the Institute of Clinical PET (ICP)
At this briefing, researchers will present and discuss findings on the use of PET in the diagnosis and management of cancer patients, Fluorocholine as a PET tumor imaging agent, using PET to document cellular changes that lead to coronary artery endothelial dysfunction preceding plaque formation in a high fat meal compared to a low fat Olestra meal, determining tumor response to chemotherapeutic agents, and comparing PET and computerized tomography for staging melanoma patients.
Lunch will be available at the briefing.
Since the briefing is part of the 12th Annual International PET Conference, you are invited to attend and cover all sessions at the world's premier clinical PET meeting. The Conference sessions begin at the Grand Hyatt Hotel at 8:30 a.m. on Sunday, October 15 and runs through 12 noon on Wednesday, October 18. The meeting features the presentation of new research findings, state-of-the-art presentations by plenary speakers, and workshops. A program overview is included for your convenience.
If you would like to attend and cover meeting sessions in addition to the October 17 media briefing, please contact me (703-532-3797) or Stephanie Mensh (202-530-0990) in order to arrange for a complimentary press registration and badge.